Leadership Team

Demir Bingol

Demir Bingol Chief Executive Officer, Grünenthal USA, Inc. Demir Bingol
Chief Executive Officer, Grünenthal USA, Inc.

Demir Bingol is an experienced pharmaceutical executive and has served as Chief Executive Officer of Grünenthal USA, Inc. since January 2018.

Mr. Bingol joined Grünenthal in 2013 as Vice President, Business Expansion for North America and later as Vice President BD&L for the Americas in 2015. Mr. Bingol has over 20 years of commercial pharmaceutical and healthcare experience.

Prior to joining Grünenthal, Mr. Bingol held the position of Vice President, Commercial Marketing at WellDoc, helping to launch the company’s new to the world, first in class mobile health technology for the treatment of Type II Diabetes. From 2006 – 2011, Mr. Bingol held the position of Sr. Marketing Director, Oral Analgesics at Endo Pharmaceuticals where he launched the Opana franchise and managed Endo’s portfolio of branded oral analgesics. Prior to Endo Pharmaceuticals, Mr. Bingol held positions of increasing responsibility with Adolor Corporation, aaiPharma, and AstraZeneca.

Mr. Bingol holds a Masters of Business Administration degree from Old Dominion University.